Cardlytics (CDLX) Projected to Post Earnings on Thursday

Cardlytics (NASDAQ:CDLX) will likely be posting its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Cardlytics to post earnings of ($1.93) per share and revenue of $37.07 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Wednesday, August 5th. The company reported ($1.50) earnings per share for the quarter, beating the consensus estimate of ($2.30) by $0.80. The firm had revenue of $36.88 million for the quarter, compared to analyst estimates of $37.00 million. Cardlytics had a negative net margin of 55.92% and a negative return on equity of 956.56%. On average, analysts expect Cardlytics to post ($3.89) EPS for the current fiscal year and $1.90 EPS for the next fiscal year.

Cardlytics Price Performance

CDLX stock opened at $2.08 on Tuesday. The stock has a market capitalization of $12.06 million, a PE ratio of -0.11 and a beta of 0.70. The company’s 50-day moving average is $2.98 and its 200-day moving average is $6.18. Cardlytics has a 1 year low of $1.57 and a 1 year high of $19.50.

Insiders Place Their Bets

In other Cardlytics news, CEO Amit Gupta sold 10,351 shares of the firm’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $2.71, for a total value of $28,051.21. Following the transaction, the chief executive officer directly owned 146,288 shares of the company’s stock, valued at approximately $396,440.48. This trade represents a 6.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 31,194 shares of company stock worth $100,568 in the last 90 days. Corporate insiders own 5.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CDLX shares. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, September 19th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a report on Friday, October 2nd. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Sell” and an average price target of $10.00.

Cardlytics Company Profile

Cardlytics, Inc is a financial technology and advertising company that operates a marketing platform through banks and other financial institutions. Its technology connects consumers with targeted merchant offers based on transaction data, while providing advertisers with a way to reach customers through digital banking applications and other financial channels.

The company’s platform supports merchant-funded rewards, cash-back promotions and purchase-based advertising. Participating consumers can receive offers from retailers, restaurants, travel providers and other businesses, while advertisers can use Cardlytics’ data and measurement tools to target audiences and evaluate whether campaigns lead to purchases.

Cardlytics was founded in 2008 by Scott Grimes and Lynne Laube and is headquartered in Atlanta, Georgia.